Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Han, Qiuju ^a   Zhang, Cai ^a   Zhang, Jian ^a   Tian, Zhigang ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DOUBLE STRANDED RNA; INITIATION FACTOR 2ALPHA; INTERFERON; MESSENGER RNA; PROTEIN KINASE R; SMALL INTERFERING RNA; AUTACOID; HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; INTERFERON STIMULATED GENE 15; INTERFERON STIMULATED GENE 56; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; BIOSYNTHESIS; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM;

EIF-2 KINASE; ENZYME ACTIVATION; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERFERON TYPE I; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 82955201589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027931     Document Type: Article

References (46)

1. Seeger C, Mason WS, (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68.
2. Hannon GJ, (2002) RNA interference. Nature 418: 244-251.
3. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T, (2001) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20: 6877-6888.
4. Konishi M, Wu CH, Wu GY, (2003) Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology 38: 842-850.
5. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, et al. (2003) Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 21: 639-644.
6. Morrissey DV, Blanchard K, Shaw L, Jensen K, Lockridge JA, et al. (2005) Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41: 1349-1356.
7. Shlomai A, Shaul Y, (2003) Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37: 764-770.
8. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, et al. (2009) Activation of innate immune antiviral responses by Nod2. Nat Immunol 10: 1073-1080.
9. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, et al. (2010) RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140: 397-408.
10. Habjan M, Andersson I, Klingstrom J, Schumann M, Martin A, et al. (2008) Processing of genome 5′ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 3: e2032.
11. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
12. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, et al. (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205: 1601-1610.
13. Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, et al. (2008) Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 29: 428-440.
14. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
15. Kariko K, Bhuyan P, Capodici J, Weissman D, (2004) Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 172: 6545-6549.
16. Sioud M, (2005) Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 348: 1079-1090.
17. Judge AD, Sood V, Shaw JR, Fang D, McClintock K, et al. (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23: 457-462.
18. Bourquin C, Schmidt L, Lanz AL, Storch B, Wurzenberger C, et al. (2009) Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7. J Immunol 183: 6078-6086.
19. Zhang Z, Weinschenk T, Guo K, Schluesener HJ, (2006) siRNA binding proteins of microglial cells: PKR is an unanticipated ligand. J Cell Biochem 97: 1217-1229.
20. Nayak R, Pintel DJ, (2007) Adeno-associated viruses can induce phosphorylation of eIF2alpha via PKR activation, which can be overcome by helper adenovirus type 5 virus-associated RNA. J Virol 81: 11908-11916.
21. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR, (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5: 834-839.
22. Armstrong ME, Gantier M, Li L, Chung WY, McCann A, et al. (2008) Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism. J Immunol 180: 7125-7133.
23. Gorina R, Santalucia T, Petegnief V, Ejarque-Ortiz A, Saura J, et al. (2009) Astrocytes are very sensitive to develop innate immune responses to lipid-carried short interfering RNA. Glia 57: 93-107.
24. Davis AM, Hagan KA, Matthews LA, Bajwa G, Gill MA, et al. (2008) Blockade of virus infection by human CD4+ T cells via a cytokine relay network. J Immunol 180: 6923-6932.
25. Kuo TM, Hu CP, Chen YL, Hong MH, Jeng KS, et al. (2009) HBV replication is significantly reduced by IL-6. J Biomed Sci 16: 41.
26. Saelens X, Kalai M, Vandenabeele P, (2001) Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-alpha phosphorylation. J Biol Chem 276: 41620-41628.
27. Cho WG, Albuquerque RJ, Kleinman ME, Tarallo V, Greco A, et al. (2009) Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc Natl Acad Sci U S A 106: 7137-7142.
28. Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, et al. (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 11: 263-270.
29. Manche L, Green SR, Schmedt C, Mathews MB, (1992) Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol 12: 5238-5248.
30. Nanduri S, Carpick BW, Yang Y, Williams BR, Qin J, (1998) Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J 17: 5458-5465.
31. Armstrong ME, Gantier M, Li L, Chung WY, McCann A, et al. (2008) Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism. J Immunol 180: 7125-7133.
32. Clemens MJ, Elia A, (1997) The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 17: 503-524.
33. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, et al. (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70: 1032-1060.
34. Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, et al. (1998) Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J 17: 6888-6902.
35. Donze O, Dostie J, Sonenberg N, (1999) Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression. Virology 256: 322-329.
36. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, et al. (2000) Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13: 129-141.
37. Yu S, Chen J, Wu M, Chen H, Kato N, et al. (2010) Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol 91: 2080-2090.
38. Xu Y, Hu Y, Shi B, Zhang X, Wang J, et al. (2009) HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 46: 2640-2646.
39. Jiang J, Tang H, (2010) Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein. Protein Cell 1: 1106-1117.
40. Wu J, Meng Z, Jiang M, Pei R, Trippler M, et al. (2009) Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49: 1132-1140.
41. Wang X, Li Y, Mao A, Li C, Tien P, (2010) Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex. Cell Mol Immunol 7: 341-348.
42. Wei C, Ni C, Song T, Liu Y, Yang X, et al. (2010) The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol 185: 1158-1168.
43. Han Q, Zhang C, Zhang J, Tian Z, (2011) Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology 54: 1179-1189.
44. Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, et al. (2009) Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50: 1773-1782.
45. Zhang W, Yang H, Kong X, Mohapatra S, San Juan-Vergara H, et al. (2005) Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 11: 56-62.
46. Khairuddin N, Gantier MP, Blake SJ, Wu SY, Behlke MA, et al. (2011) siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo. Immunol Cell Biol.